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Abstract
MUC5AC was deemed to be involved in gastric carcinogenesis since aberrant MUC5AC expression has been repeatedly
detected in patients with gastric cancer (GC). In this study, length polymorphisms in a complicated repetitive region
adjacent to MUC5AC promoter were assessed in 230 patients with GC and 328 cancer-free controls. Alleles of 1.4 and 1.8 kb
were significantly more prevalent in GC group than in controls. In contrast, 2.3 and 2.8 kb alleles occurred at significantly
lower frequencies in patients than in controls. Alleles were then classified into susceptible (S; 1.4 and 1.8 kb), protective (P;
2.3 and 2.8 kb) and null (N; all other alleles) categories with respect to their linkage with the susceptibility to GC. Individuals
with genotype SS had a 2.7-fold increased risk of GC occurrence, but PN genotype was associated with a significantly
reduced risk of this cancer. Moreover, homozygous or heterozygous individuals with one or two copies of 1.4 kb allele
showed an earlier age of onset and more advanced metastasis stage compared with patients without this allele (Bonferroni
corrected p = 1.3561024 and 6.6061024 accordingly), whereas homozygous patients with two copies of 1.8 kb allele were
linked to less advanced GC TNM stage. Our results suggest that certain genetic variations in MUC5AC upstream repetitive
region are associated with the susceptibility and progression of GC.
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Introduction
Gastric cancer (GC) is one of the most common malignancies
and the second leading cause of cancer-related death worldwide
[1]. However, its mechanism remains unclear. Although some
environmental factors, such as diet, cigarette smoking and
Helicobacter pylori, may contribute to carcinogenesis of gastric
epithelial cells [2–4], only a fraction of the population exposed to
such risk factors develop GC during their lifetime. This suggests
that genetic factors play a crucial role in determining an
individual’s susceptibility to GC [5,6].
Mucins are a group of diverse, complex, highly glycosylated
extracellular proteins important in maintaining epithelial homeo-
stasis. Cancer cells are often observed to express aberrant forms or
amounts of mucins, and these aberrations are thought to play a
role in carcinogenesis, especially in regulation of tumor cell
differentiation, proliferation, and tumor invasion [7]. For example,
overexpression of MUC1 and MUC4 in several different forms of
adenocarcinoma contributed to the regulation of cancer cell
proliferation via an interaction with epidermal growth factor
regulator (EGFR) and extracellular signal-regulated kinases [8].
Velcich et al. demonstrated that Muc22/2 mice develop adenomas
in the intestine that progress to invasive adenocarcinomas [9],
suggesting a protective role for MUC2 in intestinal tumorigenesis.
MUC5AC is a secreted gel-forming mucin and a marker of
gastric foveolar epithelial cells [10]. MUC5AC was deemed to be
involved in gastric carcinogenesis since gastric carcinoma was
found to contain a lower level of MUC5AC expression than
normal gastric mucosa [11–13], and several clinical studies
demonstrated that MUC5AC expression level was associated with
severity of GC; however, these data were inconsistent [12,14].
There has been little research on MUC5AC function and the
mechanisms underlying its role in GC development, until recently
it was reported that silencing MUC5AC, using a small hairpin
RNA-containing lentivirus, increased gastric cancer cell invasion
and migration in vitro [13]. This adds to evidence that altered
levels of MUC5AC expression may be involved in GC pathogen-
esis. Functional genetic polymorphisms in the regulation region
may affect MUC5AC gene expression and then contribute to an
individuals’ susceptibility to gastric cancer.
Repetitive regions of DNA are common throughout the human
genome and are characterized by their dynamic, unstable features
[15,16]. They are the major generator of genetic variation and are
considered to underlie substantial genetic variability, with novel
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mutations in such regions explaining much of the ‘missing’
heritability in polygenic diseases [17,18], including GC [19].
However, this kind of genetic variation cannot be included in
genome-wide association studies (GWAS) panels and is challeng-
ing to assess reliably. Intensive review of the MUC5AC upstream
regulation region and around identified a complicated repetitive
region (termed MUC5AC-u repetitive region). We undertook this
case-control study to determine the nature and extent of genetic
polymorphisms within this region, and to explore the association
of each genetic variant with the occurrence and progression of
GC.
Methods
Database searches and analysis of the upstream region
of MUC5AC
The UCSC genome browser (http://genome.ucsc.edu) and the
GRCh37/hg19 release of the human genome were used to
generate a map showing the location and major genomic features
of the MUC5AC gene, including histone H3 lysine 27 acetylation
(H3K27AC) status, transcription factor binding sites, common
single-nucleotide polymorphisms (SNPs), and repetitive sequence
genomic features of the upstream region. The DNA sequence of
the upstream region was downloaded from the Ensembl (http://
useast.ensembl.org/Homo_sapiens/ Info/Index).
Ethics statement
This study was conducted with the approval of the Medical
Ethics Committee of Shandong University and informed written
consent was received from all subjects. The manuscript does not
contain identifying patient information. The data were analyzed
anonymously and all clinical investigations were conducted
according to the principles expressed in the Declaration of
Helsinki.
Study subjects
Two hundred and thirty patients with GC were recruited in
Shandong Province, northeastern China, between January 2011
and December 2012. All diagnoses of GC were pathologically
confirmed; exclusion criteria included a history of cancer of any
other organ (not originally from stomach) or having undergone
radiotherapy or chemotherapy. Three hundred and twenty-eight
cancer-free individuals without any detectable or known cancers
were collected as controls. All these subjects were living in the
same residential areas as the cases, the vast majority of them were
selected from the healthy volunteers, and a small portion of our
aged controls were collected from inpatients with mild cardiovas-
cular diseases of the hospitals. Their age and sex were matched
with those of patients with GC. All subjects were genetically
unrelated ethnic Han Chinese. Each subject was evaluated
individually with a pretested questionnaire to obtain demographic
data and information on related risk factors, including tobacco
smoking and alcohol consumption. Individuals who smoked at
least once a day for longer than one year were defined as smokers,
and those who consumed three or more alcoholic drinks per week
for more than six months were considered alcohol drinkers.
Clinical data and pathological characteristics of patients were
collected and confirmed from their medical history records and
questionnaires, and GC tumor, node and metastasis (TNM) stages
were classified according to the system of the World Health
Organization (WHO).
Specimens and DNA extraction
One mL peripheral blood sample was collected from each
subject. Genomic DNA was isolated from each sample using a
modified salt extraction technique [20].
We obtained tissue samples from 36 GC patients in our cohort,
and samples from each patient consisted of cancerous tissue, the
respective para-carcinoma (defined as being 1.0 cm away from the
tumor mass) and surrounding noncancerous gastric mucosal
tissues. Genomic DNA was extracted from these samples using
the Blood and Cell Culture DNA Mini Kit (Tiangen Biotech,
Beijing, China).
Assessment of allele sizes
MUC5AC-u repetitive region genotyping was performed using
the polymerase chain reaction (PCR); the gene-specific primer
sequences used were as follows: sense 59- TCCACCC-
TAACCCTGTCAGCCGC-39; antisense 59- GTGGCAG-
GAGTGTGGGGAAAGG G-39. PCR amplification of DNA
was performed in a total reaction volume of 50 mL, containing
100 ng genomic DNA, 0.2 mM of each primer and 25 mL
PrimeSTAR Max DNA Polymerase (Takara, Japan). PCR was
conducted in a 9700 Thermacycler (Perkin-Elmer, CA, USA) as
follows: a 5 minute initial denaturation at 94 uC, followed by 30
cycles of 10 s at 98uC and 2 minutes at 68uC. PCR products were
analyzed by gel electrophoresis (1 volt/cm) in TAE buffer through
1.0% agarose gel.
DNA sequencing assay
To confirm the genotyping results, PCR-amplified DNA
samples (amplicons) were selected and sent to BGI Tech (Beijing,
China) for purification and Sanger sequencing. This assay was
conducted blind with respect to the specimens and study design.
Statistical analysis
SPSS 13.0 software (SPSS, Chicago, IL, USA) was employed for
statistical analysis. Differences in demographic variables, smoking
and drinking habits, and grouped allelic frequencies between case
and control participants were compared using the chi-squared test
or Fisher’s exact test. Regression analyses were performed to
determine the odds ratios (ORs) for association of GC and
MUC5AC-u repetitive region genotypes between the controls and
GC patients. ORs were estimated using the natural logarithm and
its standard error. The chi-squared test or Fisher’s exact test were
used for comparison of clinical and pathological characteristics of
patients. In order to allow multiple comparisons, p values were
corrected (pc) using the Bonferroni correction; pc = p631 as,
across the whole study, 31 statistical tests were conducted. All tests
were two-sided, with pc,0.05 considered to be statistically
significant.
Results
Identification of the MUC5AC-u repetitive region
Intensive review of the MUC5AC upstream region identified a
complicated 1710 bp repetitive region (termed the MUC5AC-u
repetitive region) located between nucleotides 23162 to 21452
upstream from the ATG initiation codon (Figure 1). This position
is immediately downstream of a genomic locus with the capacity to
bind several transcription factors. The MUC5AC-u repetitive
region contains many interrupted irregular repeats of different
lengths and is a complicated combination of microsatellite (e.g.,
CTCA), minisatellite (e.g., CATTCACT or CATTCACTCATT)
MUC5AC Upstream Repetitive Region and Gastric Cancer
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and megasatellite (e.g., ACCCATTCACTCACTCACTTATT-
CACTC) repeats. At the 59 region, a 300 bp sequence was found
to be duplicated exactly, head-to-tail.
Study population
All individuals in the study (328 cancer-free controls and
230 GC patients) were from a Han Chinese population and
without any known hereditary disease. Both groups had similar
distributions of age, sex and alcohol consumption (x2 test;
Figure 1. Location and genomic features of the upstream region of the human MUC5AC gene. The studied MUC5AC-u repetitive region
(red and black boxes) is located about 1.5 kb upstream from the MUC5AC mRNA transcript start, the MUC5AC transcript is incorrectly annotated to
MUC5B (UCSC Genome Brower, GRCh 37/hg 19). This locus snapshot illustrates its location, the PCR coverage in amplifying the target region (open
box with vertical lines), the major repetitive genomic features defined by Repeat Master, the histone H3 lysine 27 acetylation (H3K27AC) enrichment
and reported transcription factor binding sites, and many more other features.
doi:10.1371/journal.pone.0098327.g001
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p = 0.875, p = 0.589, p = 0.770, respectively; Table S1). There was
no significant difference in the distribution of cigarette smoking
between the patients and controls (p = 0.098). According to the
TNM system, 10.9%, 10.0%, 21.7%, 42.2% and 15.2% of
patients had stage 0, I, II, III and IV disease, respectively (Table
S2).
Association of repetitive region genotypes with the risk
of GC
Genomic DNA samples were isolated from whole blood of all
the subjects and used as templates to amplify the MUC5AC-u
repetitive region. Eight alleles with discontinuous sizes ranging
from 1.1 to 2.8 kb were identified in this Han Chinese population
(Figure 2). The 1.1 kb allele was most common, the 1.8 and 2.0 kb
alleles were less common, and the others were all relatively
uncommon (Table 1).
The overall distribution of the MUC5AC-u repetitive region
alleles among patients with GC differed significantly from that
found in controls (x2 = 58.44, p = 3.09610210). For further
analysis, comparisons of allele frequencies between patients and
controls were made individually for each allele, using Fisher’s test
(Table 1). The 1.4 and 1.8 kb alleles were significantly more
prevalent in patients with cancer than in controls (3.9% vs. 0.0%,
pc = 3.0061026; 35.4% vs. 25.8%, pc = 1.5661022, respectively).
Additionally, the frequencies of the 2.3 and 2.8 kb alleles were
significantly lower in patients with cancer than in controls (3.3%
vs. 9.0%, p = 1.5161024; 0.0% vs. 1.8%, p = 0.002, respectively),
and the multiple comparisons corrected p values were 4.6861023
for the 2.3 kb and 0.062 (suggestive) for the 2.8 kb allele. No
significant differences were found when frequencies of other alleles
between cases and controls were compared.
Based on these observations, we classified the eight alleles as
susceptible (S), protective (P), or null with respect to risk (N) as
follows: S, 1.4 or 1.8 kb; P, 2.3 or 2.8 kb; and N, all other alleles.
Twenty-one MUC5AC-u repetitive region genotypes were totally
identified in our case-control population (Table S3), the genotypes
were then defined as NN, SN, PN, SP, SS, and there was no PP
genotype in our cohort. The most common genotype (NN) was
designated as the reference group. Individuals with the homozy-
gous genotype SS had a 2.7-fold increased risk of GC occurrence
(OR = 2.683, 95% CI = 1.554–4.361, pc = 0.012; Table 2). The
PN genotype was associated with a significantly reduced risk of
GC (OR = 0.257, 95% CI = 0.116–0.569, pc = 0.031). Neither of
the heterozygous genotypes SN and SP was associated with a
change in the risk of GC (both p.0.05).
Clinical and pathological characteristics at diagnosis of
GC patients with differing MUC5AC-u repetitive regions
As certain variable number of tandem repeat polymorphisms
are reported to exert dual, conflicting effects on the risk and
prognosis of cancer [21], we compared the age at onset and
clinical stages between GC patients with and without MUC5AC-u
repetitive regions of 1.4, 1.8 or 2.3 kb separately.
In our sample, fifteen GC patients (6.5%) carried the 1.4 kb
allele; three of them were homozygous for this allele and the
remainder were heterozygous. Significantly higher percentages of
GC patients with at least one copy of the 1.4 kb allele were
younger (,50 years) individuals or with more advanced T (T4)
and M (M1) stages compared with those lacking it (66.7% vs.
17.2%, p = 4.3761026; 93.3% vs. 58.6%, p = 0.006; 53.3% vs.
12.6%, p = 2.1361025, respectively; pc values = 1.3561024,
0.186 and 6.6061024, respectively, after correcting for multiple
comparisons; Table 3).
There were 128 GC patients (55.7%) in our sample who carried
the 1.8 kb version of the MUC5AC-u repetitive region; 35 patients
Figure 2. Representative alleles of MUC5AC-u repetitive region.
MUC5AC-u repetitive regions were PCR-amplified from blood genomic
DNA of case and control samples using specific unique primers. Eight
alleles with discontinuous sizes ranging from 1.1 to 2.8 kb were
identified in this Han Chinese population. Lane 1: 1.1 kb/2.3 kb; lane 2:
1.1 kb/2.1 kb; lane 3: 1.4 kb/1.8 kb; lane 4: 2.0 kb/2.8 kb; lane 5: 2.5 kb/
2.5 kb. M indicated the size marker.
doi:10.1371/journal.pone.0098327.g002
Table 1. Distribution of MUC5AC-u repetitive region alleles among cases and controls.
Allele size n (%) Cases vs. controls
(kb) Cases (n = 460) Controls (n = 656) OR 95% CI p pc
1.1 197 (42.8) 307 (46.8) 0.852 0.670–1.083 0.189
1.4 18 (3.9) 0 (0.0) - - 9.6761028 3.0061026
1.8 163 (35.4) 169 (25.8) 1.582 1.221–2.049 5.0361024 1.5661022
2.0 50 (10.9) 78 (11.9) 0.904 0.620–1.317 0.598
2.1 5 (1.1) 6 (0.9) 1.190 0.361–3.924 0.774
2.3 15 (3.3) 59 (9.0) 0.341 0.191–0.609 1.5161024 4.6861023
2.5 12 (2.6) 25 (3.8) 0.676 0.336–1.360 0.269
2.8 0 (0.0) 12 (1.8) - - 0.002 0.062
pc, p value corrected using the Bonferroni correction for multiple comparisons. 31 statistical tests were totally conducted in the whole study, and pc = p631.
doi:10.1371/journal.pone.0098327.t001
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were homozygous for this allele. Homozygous patients tended to
have an older age of onset ($ 50 years), and less advanced T (Tis-
T3), N (N0), and TNM (stage 0–II) stages compared with patients
who were not homozygous for the 1.8 kb allele (5.7% vs. 23.1%,
p = 0.021; 60.0% vs. 35.4%, p = 0.006; 51.4% vs. 29.2%,
p = 0.010; 68.6% vs. 37.9%, p = 7.4361024, respectively), al-
though most of the nominally significant p values did not survive
the Bonferroni correction (Table 4).
We did not find individuals showing the homozygous genotype
2.3/2.3 kb in our sample; however, fifteen GC patients (6.5%)
were heterozygous for this allele. Heterozygous patients were older
at GC onset than patients who were not, although this result was
at a marginal level of significance and did not survive the
correction for multiple tests. There was no significant difference in
distributions of T, N, M or TNM stages of cancer between patients
with one or no copy of the 2.3 kb allele (Table 5).
Analysis of repetitive region instability in cancer tissues
As repetitive regions of DNA are unstable in various human
malignancies, including GC [22], we next determined whether the
hypervariable MUC5AC-u repetitive regions differed in length
between cancer, para-carcinoma and surrounding normal tissues
from 36 GC patients. The results showed no differences in band
pattern between para-carcinoma and normal tissues in all 36
patients; however, length alterations were observed in DNA
samples of cancer tissues in two GC patients (Figure 3). In both
cases, bands were detected showing a shift from long alleles in
cancer tissue to short alleles in para-carcinoma tissue. In one case,
one allele shifted from 2.0 kb to a novel, 0.9 kb allele, and, in
another case, one allele shifted from 2.3 kb to 1.4 kb. Among the
36 gastric cancer patients tested, the frequency of cancer-related
genome rearrangement in the MUC5AC-u repetitive region was
5.6%.
Sanger sequencing of the 1.1, 1.4 and 1.8 kb alleles from
three GC patients
PCR amplicons of the 1.1 kb and 1.4 kb alleles from the gastric
cancer tissue DNA were successfully sequenced using the Sanger
sequencing technique. These sequences are listed in supporting
information files. We were unable to sequence the entire fragment
of a 1.8 kb amplicon (PCR amplicon using the gastric cancer tissue
DNA), or any other fragments .1.8 kb, due to the complicated
and repetitive structure of the target region and limitations of the
technique. The sequences show the same main genetic structure
and repetitive units as the UCSC genome reference sequence but
with different overall lengths. The initial 300 bp at the 5’ end of
the 1.4 kb MUC5AC-u repetitive region sequence are exactly
duplicated in a head-to-tail pattern.
Discussion
In this study, we assessed the association of genetic variation in a
repetitive region close to the MUC5AC promoter with the risk of
occurrence and progression of GC. Our study was suggested by
the diverse biological functions of MUC5AC in the healthy and
diseased states, the unique location of the region potential
regulating the gene expression, the highly dynamic nature of the
repetitive sequence, and the effect of this instability on generating
novel mutations.
Analysis of 230 GC patients and 328 controls showed the
MUC5AC-u repetitive region was highly polymorphic, with eight
different alleles (plus a 0.9 kb allele in the cancer tissue from one
GC patient) being present in a Han Chinese population from
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allelic frequencies between GC patients and controls, these eight
alleles were classified into susceptible alleles (S: 1.4 and 1.8 kb),
protective alleles (P: 2.3 and 2.8 kb), and null alleles (N: the
others). Individuals bearing two susceptible alleles (SS) had a 2.7-
fold increased risk of developing GC, and the genotype PN was
associated with a reduced risk of gastric cancer. Our findings
suggest that genetic variation in this region is significantly
associated with susceptibility to GC, and thus add to the existing
evidence that changes in MUC5AC expression is involved in the
pathogenesis of this malignant disease.
In further analysis, we found that these genetic variants were not
only associated with GC susceptibility, but also with its prognosis.
We found patients with the 1.4 kb allele had an earlier age of GC
onset and were more likely to have advanced T and M stage
diseases. As advanced T and M stages are associated with a poor
prognosis in general, our results indicated that GC patients with
the 1.4 kb allele were linked to more rapid progression of the
disease. In contrast, patients homozygous for the 1.8 kb allele
tended to have an older age at diagnosis and less advanced T, N,
and TNM stages than other patients, indicating this genotype
Table 3. Clinical and pathological characteristics of GC patients with MUC5AC-u repetitive region 1.4 kb allele.
1.4 kb/1.4 kb+1.4 kb/non-1.4 kb n (%) non-1.4kb/non-1.4 kb n (%) p pc
Total cases 15 (6.5) 215 (93.5)
Age (years)
,50 10 (66.7) 37 (17.2) 4.3761026 1.3561024
$ 50 5 (33.3) 178 (82.8)
T stage
Tis-T3 1 (6.7) 89 (41.4) 0.006 0.186
T4 14 (93.3) 126 (58.6)
N stage
N0 5 (33.3) 70 (32.6) 0.951
N1-3 10 (66.7) 145 (67.4)
M stage
M0 7 (46.7) 188 (87.4) 2.1361025 6.6061024
M1 8 (53.3) 27 (12.6)
TNM stage
Stage 0–II 3 (20.0) 95 (44.2) 0.103
Stage III–IV 12 (80.0) 120 (55.8)
pc, p value corrected using the Bonferroni correction for multiple comparisons. 31 statistical tests were totally conducted in the whole study, and pc = p631.
doi:10.1371/journal.pone.0098327.t003
Table 4. Clinical and pathological characteristics of GC patients with MUC5AC-u repetitive region 1.8 kb allele.
1.8 kb/1.8 kb n (%) 1.8 kb/non-1.8 kb+ non-1.8 kb/non-1.8 kb n (%) p pc
Total cases 35 (15.2) 195 (84.8)
Age (years)
,50 2 (5.7) 45 (23.1) 0.021 0.651
$50 33 (94.3) 150 (76.9)
T stage
Tis-T3 21 (60.0) 69 (35.4) 0.006 0.186
T4 14 (40.0) 126 (64.6)
N stage
N0 18 (51.4) 57 (29.2) 0.010 0.31
N1-3 17 (48.6) 138 (70.8)
M stage
M0 33 (94.3) 162 (83.1) 0.124
M1 2 (5.7) 33 (16.9)
TNM stage
Stage 0–II 24 (68.6) 74 (37.9) 7.4361024 0.023
Stage III–IV 11 (31.4) 121 (62.1)
pc, p value corrected using the Bonferroni correction for multiple comparisons. 31 statistical tests were totally conducted in the whole study, and pc = p631.
doi:10.1371/journal.pone.0098327.t004
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might decrease the risk of developing advanced gastric cancer and
be associated with a better outcome.
Repetitive regions of the genome have been dismissed as
nonfunctional ‘‘junk’’ DNA previously; however, a recent study
found that up to 25% of gene promoters in the Saccharomyces
cerevisiae genome contain repetitive sequences [23]. A comparable
distribution of tandem repeats in the promoters of Homo sapiens
genes also demonstrated that genes driven by repeat-containing
promoters had significantly higher rates of transcriptional diver-
gence [23]. A number of studies have shown that many variations
in repetitive regions of promoters affect gene expression and
contribute to genetic susceptibility to various human disorders
[24–26], and for cancers as well [27–29]. Several molecular
mechanisms may underlie the effects of repetitive regions in
promoters on gene expression; for example, they may alter the
number of transcription factor binding sites, generate changes in
the spacing of critical promoter elements, modulate the activity of
RNA-binding proteins or affect the chromatin structure [23].
According to the Encyclopedia of DNA Elements (ENCODE)
dataset, available for visualization and download via the UCSC
Genome Browser (http://genome.ucsc.edu/), the region contain-
ing the MUC5AC-u repetitive region contains clusters of known
transcription factor binding sites and is enriched for histone H3
lysine 27 acetylation (H3K27ac), a reliable marker for active
chromatin. Thus length variations of this repetitive region might
have considerable impact on DNA structure and transcription
factor binding, and hence upon gene regulation. Therefore, our
finding of an association between the length of the repetitive
region and a change in GC risk might be explained by alterations
in MUC5AC levels. This will be explored in future studies, which
will investigate whether the 1.4 and 1.8 kb alleles enhance
promoter activity and if 2.3 and 2.8 kb alleles repress it. Such
studies will help to reveal the exact role this region plays in the
development and prognosis of GC.
Genomic instability was shown to affect tumor initiation and
progression by accelerating the accumulation of the multiple
genetic alterations responsible for cancer cell development [30].
Although spontaneous rearrangements of repetitive regions were
detected more frequently in the germ line than in somatic cells
[31], several studies have demonstrated repetitive regions are
unstable in various human neoplasms [32–34], including GC [35].
When we examined the MUC5AC-u repetitive region length in
DNA from normal and cancer tissues from some GC patients, we
found two examples of length alterations. Both converted long to
short alleles, and the 1.4 kb allele, associated in our study with an
increased risk of GC, appeared in one case. Although the genetic
rearrangement frequency was relatively low, this result implies that
instability at this locus contributes to the pathogenesis of gastric
cancer in some cases.
The duplication of a 300 bp DNA segment at the beginning of
this complicated repetitive region is relevant in this context. This
duplication is likely to have occurred multiple times to form the
larger allelic variants, which differ from each other mostly in
Table 5. Clinical and pathological characteristics of GC patients with MUC5AC-u repetitive region 2.3 kb allele.
2.3 kb/non-2.3 kb n (%) non-2.3 kb/non-2.3 kb n (%) p pc
Total cases 15 (6.5) 215 (93.5)
Age (years)
,50 0 (0.0) 47 (21.9) 0.045 1.000
$50 15 (100.0) 168 (78.1)
T stage
Tis-T3 6 (40.0) 84 (39.1) 0.943
T4 9 (60.0) 131 (60.9)
N stage
N0 3 (20.0) 72 (33.5) 0.396
N1-3 12 (80.0) 143 (66.5)
M stage
M0 13 (86.7) 182 (84.7) 1.000
M1 2 (13.3) 33 (15.3)
TNM stage
Stage 0–II 5 (33.3) 93 (43.3) 0.452
Stage III–IV 10 (66.7) 122 (56.7)
pc, p value corrected using the Bonferroni correction for multiple comparisons. 31 statistical tests were totally conducted in the whole study, and pc = p631.
doi:10.1371/journal.pone.0098327.t005
Figure 3. Instability of MUC5AC-u repetitive region in normal,
para-carcinoma, and cancer tissues from patients with gastric
cancers. Genomic DNA was analyzed from cancer, para-carcinoma and
surrounding normal tissues of patients. The sizes of MUC5AC-u
repetitive region were analyzed by PCR. N indicated gastric normal
tissues, C indicated cancer tissues, P indicated para-carcinoma tissues,
and M indicated the size marker. Rearrangements in cancer tissues are
indicated by arrows. Heterozygotes have an additional hetero-duplex
band (lane of 2C).
doi:10.1371/journal.pone.0098327.g003
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,300 bp increments. For example, we speculate the 1.4 kb allele
was generated by this duplication from the 1.1 kb allele, which is
the most common allele in our study population. This duplication
event may be associated with genome instability which is
extensively involved in tumorigenesis, development and metastasis
of gastric cancer. There are reports of similar duplication events in
large central repetitive exons of MUC5AC [36].
Although we did not achieve novel sequences distinguishing
them with the reference sequence in three selected GC patients,
from 1.1, 1.4 and 1.8 kb allele DNA fragments, we found many
SNPs, which could possibly be used as proxies for allele sizes and
in strong LD with other genetic markers outside of the region,
besides of the length differences. Due to the great complexity,
length, high similarity across the region, and the limits of the
sequencing technique, we could not sequence the entire region of
the DNA amplicons from all subjects; thus, other sequencing
features and genetic variants have not been revealed very likely.
Moreover, we can not tell if there are more dramatic genetic
mutation events occurred in the genome DNA of the cancer tissue
which will be more challenging, but likely more productive.
To the best of our knowledge, this is the first report to indicate
the association between genetic variation in MUC5AC-u repetitive
region and gastric cancer risk. We have shown certain genetic
length variants in the repetitive region around the MUC5AC
promoter are significantly associated with susceptibility to GC, and
with its clinical stages. Prospective, large-scale trials, as well as
well-designed mechanistic studies, are required to validate our
findings.
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